Edgewise Therapeutics, Inc. (EWTX) SEC Filings — 2024

Filings

• Edgewise Therapeutics Files 8-K — 8-K · Dec 16, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Edgewise Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• OrbiMed Amends Stake in Edgewise Therapeutics — SC 13D/A · Nov 12, 2024
• Edgewise Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Edgewise Therapeutics Files 8-K on Financials — 8-K · Nov 7, 2024
• Edgewise Therapeutics Q3 2024: Net Loss of $14.57M — 10-Q · Nov 7, 2024
• Edgewise Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• Novo Holdings Amends Edgewise Therapeutics Stake — SC 13D/A · Sep 23, 2024
• Edgewise Therapeutics Appoints New CMO, Adds Directors — 8-K · Aug 12, 2024
• Edgewise Therapeutics Files 8-K — 8-K · Aug 8, 2024
• Edgewise Therapeutics Q2 2024 Update — 10-Q · Aug 8, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
• Edgewise Therapeutics Holds Annual Meeting, Stockholder Proposals Approved — 8-K · Jun 11, 2024
• Edgewise Therapeutics Files 8-K on Agreement Changes — 8-K · May 10, 2024
• Edgewise Therapeutics Files 8-K on Financials — 8-K · May 9, 2024
• Edgewise Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Edgewise Therapeutics Files 8-K on Officer/Director Changes — 8-K · May 7, 2024
• Edgewise Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
• Edgewise Therapeutics Reports Financial Condition on Feb 22, 2024 — 8-K · Feb 22, 2024
• Edgewise Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Edgewise Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• FMR LLC & Abigail Johnson Maintain 10.23% Stake in Edgewise Therapeutics — SC 13G/A · Feb 9, 2024
• BlackRock Amends Edgewise Therapeutics Stake (SC 13G/A) — SC 13G/A · Feb 7, 2024
• BlackRock Discloses Significant Passive Stake in Edgewise Therapeutics — SC 13G · Feb 2, 2024
• Deerfield Mgmt Reports 545,455 Shared Shares in Edgewise Therapeutics — SC 13G/A · Feb 1, 2024
• RA Capital Management Discloses Passive Stake in Edgewise Therapeutics — SC 13G · Jan 29, 2024
• Novo Holdings A/S Amends Edgewise Therapeutics Stake — SC 13D/A · Jan 25, 2024
• OrbiMed Amends Edgewise Therapeutics Stake on Jan 23 — SC 13D/A · Jan 25, 2024
• Edgewise Therapeutics Files Routine 8-K for Rule 425 Communications — 8-K · Jan 19, 2024